Acumen Pharmaceuticals, Inc. (ABOS) vs Immuneering Corporation (IMRX)
A side-by-side comparison of Acumen Pharmaceuticals, Inc. and Immuneering Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABOS
Acumen Pharmaceuticals, Inc.
$2.05HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
IMRX
Immuneering Corporation
$4.01HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ABOS vs IMRX
growth of $100 · dividends reinvested · last 5yABOS -86.2% (-32.7%/yr)IMRX -77.0% (-25.5%/yr)IMRX compounded faster over this window
ABOS IMRX
ABOS vs IMRX: by the numbers
- •ABOS is the larger company ($148M vs $145M market cap).
Metrics side by side
Valuation
| Metric | ABOS | IMRX |
|---|---|---|
| P/B ratio | 2.59 | 0.76 |
Profitability
| Metric | ABOS | IMRX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -183.44% | -30.03% |
| ROIC | -118.67% | -32.73% |
Growth (annualized)
| Metric | ABOS | IMRX |
|---|---|---|
| Total return CAGR (5Y) | -32.60% | -32.77% |
Frequently asked
- How have ABOS and IMRX total returns compared?
- Over the past 5 years, ABOS delivered -32.60% and IMRX delivered -32.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.